en
Scientific article
English

Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial

Published inAnnals of oncology, vol. 26, no. 1, p. 126-132
Publication date2015
Abstract

Although colon cancer (CC) with microsatellite instability (MSI) has a more favorable prognosis than microsatellite stable (MSS) CC, the impact varies according to clinicopathological parameters. We studied how MSI status affects prognosis in a trial-based cohort of stage II and III CC patients treated with 5-fluorouracil (5-FU)/leucovorin or FOLFIRI.

Citation (ISO format)
KLINGBIEL, D et al. Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial. In: Annals of oncology, 2015, vol. 26, n° 1, p. 126–132. doi: 10.1093/annonc/mdu499
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0923-7534
516views
0downloads

Technical informations

Creation03/10/2015 4:02:00 PM
First validation03/10/2015 4:02:00 PM
Update time03/14/2023 11:00:53 PM
Status update03/14/2023 11:00:53 PM
Last indexation01/16/2024 5:18:05 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack